Description
NANOSPHERE VERIGENE REAGENT IDIQ 5 YEAR CONTRACT, MODIFICATION TO CHANGE FOB POINT TO OTHER. NO COST.
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-01+$78,880= $78,880
- Mod P000012018-02-21-$20,000= $58,880
- Mod P000022018-12-10-$4,367= $54,513
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-01 | +$78,880 | $78,880 | NANOSPHERE VERIGENE REAGENT IDIQ 5 YEAR CONTRACT, MODIFICATION TO CHANGE FOB POINT TO OTHER. NO COST. |
| Mod P00001· FUNDING ONLY ACTION | 2018-02-21 | −$20,000 | $58,880 | NANOSPHERE VERIGENE REAGENT IDIQ 5 YEAR CONTRACT, MODIFICATION TO CHANGE FOB POINT TO OTHER. NO COST. |
| Mod P00002· FUNDING ONLY ACTION | 2018-12-10 | −$4,367 | $54,513 | NANOSPHERE VERIGENE REAGENT IDIQ 5 YEAR CONTRACT, MODIFICATION TO CHANGE FOB POINT TO OTHER. NO COST. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DNQ4H6RCTMJ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26220N0113 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $74,577 | FY2020 |
| 36C26219N0189 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $48,385 | FY2019 |
| 36C25919N0012 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $80,000 | FY2019 |
| 36C25918N1818 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $20,599 | FY2018 |
| 36C26018P0854 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $47,945 | FY2018 |
| 36C24418P0693 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $80,066 | FY2018 |
Other recipients under 6505 from 258-NETWORK CNTRCT OFF 22G (36C258) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25821P0342 | MCKESSON CORPORATION | 258-NETWORK CNTRCT OFF 22G (36C258) | $750 | FY2021 |
| 36C25821N0393 | UNIVERSITY OF NEW MEXICO | 258-NETWORK CNTRCT OFF 22G (36C258) | $31,866 | FY2021 |
| 36C25821P0312 | LANTHEUS MEDICAL IMAGING, INC. | 258-NETWORK CNTRCT OFF 22G (36C258) | $101,384 | FY2021 |
| 36C25821N0382 | CSL BEHRING L.L.C. | 258-NETWORK CNTRCT OFF 22G (36C258) | $152,276 | FY2021 |
| 36C25821N0375 | CARDINAL HEALTH 414, LLC | 258-NETWORK CNTRCT OFF 22G (36C258) | $182,654 | FY2021 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25817J3016_3600_VA25815D0081_3600 · retrieved 2026-09-26.